TrendsWide
Contact US
  • Home
  • Trending
  • Health
  • Life Style
  • NBA
  • Reviews
No Result
View All Result
TrendsWide
  • Home
  • Trending
  • Health
  • Life Style
  • NBA
  • Reviews
No Result
View All Result
TrendsWide
No Result
View All Result
Home Economie

Abbott Laboratories’ sales jump 9.6% in the fiscal third quarter.

by souhaib
October 21, 2020
in Economie
0
74
SHARES
1.2k
VIEWS
Share on FacebookShare on Twitter
ADVERTISEMENT


You might also like

‘momentum is continuing into 2022’

Astra Space stock closed down 20% on Monday: here’s why

Ripple, Dogecoin, Litecoin price forecast for February 2022

  • Abbott Laboratories’ sales jump 9.6% in the fiscal third quarter.
  • The health care company reports £940 million of net income in Q3.
  • Abbott forecasts at least £2.72 of adjusted EPS for the full year.

Abbott Laboratories (NYSE: ABT) published its earnings report for the fiscal third quarter on Wednesday. The company said that its earnings in Q3 came in stronger than what analysts had expected, and expressed confidence that its performance was likely to remain strong in the rest of the year.

Shares of the company slid less than 0.5% in premarket trading on Wednesday and tanked another 1.5% on market open. Abbott Laboratories is now trading at £81.51 per share that represents a close to 55% recovery since March, when the stock had touched a year to date low of £48 per share.


Are you looking for fast-news, hot-tips and market analysis?

Sign-up for the Invezz newsletter, today.

Abbott’s Q3 financial results versus analysts’ estimates

Abbott said that its net income in the third quarter came in at £940 million that translated to 52.87 pence per share. In the same quarter last year, its net income was capped at a lower £735.60 million or 40.61 pence per share.

On an adjusted basis, the medical devices company earned 75.09 pence per share in the recent quarter versus 69.73 pence per share expected, as per FactSet. In separate news from the U.S., Thermo Fisher Scientific Inc. also published its quarterly earnings report on Wednesday.

In terms of sales, the healthcare company registered a 9.6% year over year growth to £6.78 billion. According to FactSet, experts had forecast a lower £6.54 billion of revenue for Abbott in the fiscal third quarter.

The U.S. Food and Drug Authority approved Abbott’s rapid COVID-19 test for emergency use in August. The test takes only 15 minutes to deliver results. The novel Coronavirus has so far infected more than 41 million people worldwide and caused over 1.1 million deaths.

Abbott Laboratories’ guidance for the full year

For the full fiscal year, the American multinational now forecasts at least £2.72 of adjusted per-share earnings. In comparison, experts forecast a lower £2.56 per share of adjusted earnings for Abbott Laboratories this year.

CEO Robert B. Ford commented on the earnings report on Wednesday and said:

“Our strong results and increased guidance are a direct reflection of our ability to innovate and deliver despite challenging conditions, during the pandemic.”

Abbott performed fairly upbeat in the stock market last year with an annual gain of more than 20%. At the time of writing, the American multinational health care company is valued at £146 billion and has a price to earnings ratio of 61.89.



Source link

Share this:

  • Twitter
  • Facebook
  • More
  • Pinterest
  • Telegram
  • Email
Share30Tweet19
Previous Post

Nicklas Bendtner reveals that Emmanuel Adebayor is the ONLY team-mate he didn’t get on with

Next Post

Clarkson, Rayner and Laing on ‘scum’ comment in Commons

souhaib

Recommended For You

‘momentum is continuing into 2022’

by souhaib
February 7, 2022
0

Shares of Chegg Inc (NYSE: CHGG) are up 10% in extended trading on Monday after the student services company said it performed better-than-expected in Q4, despite COVID-19 uncertainty....

Read more

Astra Space stock closed down 20% on Monday: here’s why

by souhaib
February 7, 2022
0

Read more

Ripple, Dogecoin, Litecoin price forecast for February 2022

by souhaib
February 7, 2022
0

The cryptocurrency market is advancing this Monday, and this situation also supports the price of Ripple XRP/USD, Dogecoin DOGE/USD, and Litecoin LTC/USD. Bitcoin is trading above the $44,000...

Read more

Analyst: ‘Apple would be forced into it if Amazon goes after Peloton’

by souhaib
February 7, 2022
0

Read more

Should I buy Uber shares in February 2022?

by souhaib
February 7, 2022
0

Uber Technologies, Inc. (NYSE: UBER) will announce fourth-quarter earnings results this Wednesday, February 09, after the market closes. Uber shares have weakened more than 10% since the beginning...

Read more
Next Post

Clarkson, Rayner and Laing on 'scum' comment in Commons

No Result
View All Result

Recent Posts

  • Tanner Dashner’s dad asks family members to ‘be ready to forgive Tanner and me,’ all through son’s sentencing hearing
  • Embedded Fintech Services Platform Colendi Acquires London-primarily based Organization Blockchain Corporation SETL
  • Multiple casualties are reported after Amtrak derailment near Kansas City
  • What to Buy for Toddlers: 9 Gift Guide
  • NBA: Six more months of pre-trial detention in Russia for Brittney Griner

Browse by Category

  • Australia
  • Automotive
  • Business
  • Celebrity
  • Cryptocurrency
  • Deals
  • Economie
  • Education
  • Euro
  • Forex
  • Gaming
  • Health
  • Life Style
  • NBA
  • News
  • Reviews
  • Sports
  • Switzerland
  • Trending
  • U.S.
  • Uncategorized

Categories

  • Australia
  • Automotive
  • Business
  • Celebrity
  • Cryptocurrency
  • Deals
  • Economie
  • Education
  • Euro
  • Forex
  • Gaming
  • Health
  • Life Style
  • NBA
  • News
  • Reviews
  • Sports
  • Switzerland
  • Trending
  • U.S.
  • Uncategorized

Pages

  • Contact US
  • Newsletter
  • Privacy Policy
  • Terms & Conditions

© 2021 - TrendsWide

No Result
View All Result
  • Home
  • Contact US
  • Privacy Policy
  • Trending
  • U.S.
  • Economie
  • Deals
  • Reviews
  • Cryptocurrency
  • Health
  • Life Style
  • NBA

© 2021 - TrendsWide